Argenica Therapeutics Limited (ASX:AGN)
Australia · Delayed Price · Currency is AUD 0.1700
-0.0100 (-5.56%)
At close: Mar 27, 2026
Argenica Therapeutics Market Cap
Argenica Therapeutics has a market cap or net worth of 21.84 million as of March 27, 2026. Its market cap has decreased by -78.00% in one year.
Market Cap
21.84M
Enterprise Value
16.80M
Revenue
1.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.17
Market Cap Chart
Since June 11, 2021, Argenica Therapeutics's market cap has increased from 19.02M to 21.84M, an increase of 14.79%. That is a compound annual growth rate of 2.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 21.84M | -42.37% |
| Dec 31, 2025 | 37.89M | -53.04% |
| Dec 31, 2024 | 80.70M | 59.59% |
| Dec 29, 2023 | 50.57M | 29.28% |
| Dec 30, 2022 | 39.12M | -35.98% |
| Dec 31, 2021 | 61.10M | 221.15% |
| Jun 11, 2021 | 19.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 47.90M |
| EZZ Life Science Holdings | 41.89M |
| Avecho Biotechnology | 33.06M |
| Algorae Pharmaceuticals | 27.47M |
| NeuroScientific Biopharmaceuticals | 24.94M |
| Neurotech International | 18.15M |
| Noxopharm | 17.82M |
| Patrys | 15.53M |